NCT01708746View on ClinicalTrials.gov

Investigation of the Impact of Noninvasive Prenatal Testing for Fetal Aneuploidy on Utilization of Prenatal Diagnostic Procedures and Pregnant Women's Views

CompletedOBSERVATIONAL
Enrollment

205

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

September 30, 2013

Study Completion Date

October 31, 2013

Conditions
High Risk Pregnancy
Trial Locations (4)

90027

Southern California Kaiser Permanente Medical Group, Los Angeles

91367

Southern California Kaiser Permanente Medical Center, Woodland Hills

91706

Southern California Kaiser Permanente Medical Group, Baldwin Park

94102

Southern California Kaiser Permanente Medical Group, Panorama City

All Listed Sponsors
lead

Verinata Health, Inc.

INDUSTRY

NCT01708746 - Investigation of the Impact of Noninvasive Prenatal Testing for Fetal Aneuploidy on Utilization of Prenatal Diagnostic Procedures and Pregnant Women's Views | Biotech Hunter | Biotech Hunter